CYCC
Price
$7.69
Change
-$0.54 (-6.56%)
Updated
Sep 2 closing price
Capitalization
17.22M
PROK
Price
$2.30
Change
-$0.06 (-2.54%)
Updated
Sep 2 closing price
Capitalization
310.49M
76 days until earnings call
Interact to see
Advertisement

CYCC vs PROK

Header iconCYCC vs PROK Comparison
Open Charts CYCC vs PROKBanner chart's image
Cyclacel Pharmaceuticals
Price$7.69
Change-$0.54 (-6.56%)
Volume$41.45K
Capitalization17.22M
ProKidney
Price$2.30
Change-$0.06 (-2.54%)
Volume$1.25M
Capitalization310.49M
CYCC vs PROK Comparison Chart in %
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. PROK commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a StrongBuy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CYCC: $7.69 vs. PROK: $2.30)
Brand notoriety: CYCC and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 2% vs. PROK: 7%
Market capitalization -- CYCC: $17.22M vs. PROK: $310.49M
CYCC [@Biotechnology] is valued at $17.22M. PROK’s [@Biotechnology] market capitalization is $310.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, PROK is a better buy in the long-term than CYCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • CYCC’s TA Score: 3 bullish, 4 bearish.
  • PROK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CYCC is a better buy in the short-term than PROK.

Price Growth

CYCC (@Biotechnology) experienced а +2.67% price change this week, while PROK (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +24.35%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($310M) has a higher market cap than CYCC($17.2M). PROK YTD gains are higher at: 39.645 vs. CYCC (-90.874). CYCC has higher annual earnings (EBITDA): -10.41M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. CYCC (4.28M). CYCC has less debt than PROK: CYCC (10K) vs PROK (4.42M). PROK has higher revenues than CYCC: PROK (527K) vs CYCC (10K).
CYCCPROKCYCC / PROK
Capitalization17.2M310M6%
EBITDA-10.41M-157.52M7%
Gain YTD-90.87439.645-229%
P/E Ratio0.00N/A-
Revenue10K527K2%
Total Cash4.28M295M1%
Total Debt10K4.42M0%
FUNDAMENTALS RATINGS
CYCC: Fundamental Ratings
CYCC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
72%
Momentum
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
66%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
74%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSY183.753.76
+2.09%
Hershey Company (The)
EXFY1.960.01
+0.51%
Expensify
AKBA3.140.01
+0.32%
Akebia Therapeutics
CLBT16.40-0.31
-1.86%
Cellebrite DI Ltd
HUDI1.26-0.07
-5.27%
Huadi International Group Co Ltd

CYCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCC has been loosely correlated with PROK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCC jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
+5.31%
PROK - CYCC
57%
Loosely correlated
-5.60%
JSPR - CYCC
36%
Loosely correlated
-1.41%
MTVA - CYCC
26%
Poorly correlated
-1.98%
HOWL - CYCC
24%
Poorly correlated
-5.76%
DARE - CYCC
23%
Poorly correlated
-0.25%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-5.60%
CYCC - PROK
57%
Loosely correlated
+5.31%
MBIO - PROK
51%
Loosely correlated
-2.27%
RLYB - PROK
45%
Loosely correlated
-4.21%
RYTM - PROK
40%
Loosely correlated
-1.04%
NRIX - PROK
39%
Loosely correlated
-0.74%
More